We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

61 hedge funds and large institutions have $172M invested in Stemline Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 15

5% more capital invested

Capital invested by funds: $163M → $172M (+$8.31M)

12% less funds holding

Funds holding: 69 → 61 (-8)

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
61
Holders Change
-8
Holders Change %
-11.59%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
25
Reduced
15
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
TimesSquare Capital Management
New York
+$19.7M
2
Franklin Resources
Franklin Resources
California
+$9.01M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$4M
4
EAM
Eventide Asset Management
Massachusetts
+$3.74M
5
PCA
Private Capital Advisors
Connecticut
+$3.2M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$8.16M
2
SCA
SAC Capital Advisors
Connecticut
-$7.55M
3
Jennison Associates
Jennison Associates
New York
-$2.69M
4
DCM
Driehaus Capital Management
Illinois
-$1.85M
5
SM
Sabby Management
Florida
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$689K -$234K -9,660 -22%
TAM
27
Tocqueville Asset Management
New York
$601K +$279K +11,500 +64%
BIM
28
BlackRock Investment Management
Delaware
$547K +$15.3K +631 +2%
BA
29
BlackRock Advisors
Delaware
$402K -$87.4K -3,603 -15%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$391K +$43.7K +1,800 +10%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$355K – – –
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$352K – – –
HVC
33
Healthcare Value Capital
New Jersey
$335K – – –
TA
34
Teachers Advisors
New York
$311K +$61.1K +2,520 +20%
SIP
35
Stoneridge Investment Partners
Pennsylvania
$292K -$206K -8,488 -37%
Charles Schwab
36
Charles Schwab
California
$265K – – –
MLICM
37
Metropolitan Life Insurance Company (MetLife)
New York
$162K – – –
Swiss National Bank
38
Swiss National Bank
Switzerland
$157K +$58.2K +2,400 +45%
NFA
39
Nationwide Fund Advisors
Ohio
$152K – – –
AIG
40
American International Group
New York
$143K +$15.9K +657 +10%
Deutsche Bank
41
Deutsche Bank
Germany
$139K +$39.8K +1,640 +31%
Citigroup
42
Citigroup
New York
$122K +$63.6K +2,619 +79%
SO
43
STRS Ohio
Ohio
$71K – – –
Barclays
44
Barclays
United Kingdom
$55K -$172K -7,080 -72%
U
45
UBS
Switzerland
$43K +$25.2K +1,038 +100%
BG
46
BlackRock Group
United Kingdom
$42K +$49.6K +2,043 New
QT
47
Quantbot Technologies
New York
$32K +$38.8K +1,600 New
SGAM
48
Smith Group Asset Management
Texas
$29K – – –
Canada Pension Plan Investment Board
49
Canada Pension Plan Investment Board
Ontario, Canada
$14K +$17K +700 New
Teacher Retirement System of Texas
50
Teacher Retirement System of Texas
Texas
$7K +$825 +34 +10%
1
2
3

STML Hedge Fund Activity: Q1 2014 in Review

61 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q1 2014, worth a combined $172M — up 5.1% from $163M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of STML and 7 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 25 added.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $19.7M. The largest seller was Baker Bros. Advisors, cutting an estimated $8.16M.

  • 61 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q1 2014, down from 69 in Q4 2013.
  • Funds reported $172M of Stemline Therapeutics, Inc. stock for Q1 2014, up 5.1% quarter-over-quarter.
  • 7 funds opened new Stemline Therapeutics, Inc. positions in Q1 2014 and 15 closed out, a net change of -8 holders.
  • The largest Stemline Therapeutics, Inc. buyer in Q1 2014 was TimesSquare Capital Management, an estimated $19.7M added.
  • The largest Stemline Therapeutics, Inc. seller in Q1 2014 was Baker Bros. Advisors, an estimated $8.16M sold.

Based on aggregated 13F filings for Q1 2014.